About Vumedi
Vumedi is a private company based in Oakland, California. It has reported $82,081,416 raised in three offerings on Form D since August 2012. Its chief executive is Roman Giverts.
Funding Rounds (SEC Form D)
| First sale | Filed with SEC | Amount sold | Investors | Avg. check | Terms | Filing |
|---|---|---|---|---|---|---|
| May 14, 2025 | May 22, 2025 | $79,981,927fully sold | 4 | $19.9M | EquityRule 506(b) | Form D ↗ |
| Dec 29, 2017 | Jan 18, 2018 | $1,265,734of $1.7M target | 11 | $115K | Equity, Series A Preferred Stock and the Common Stock issuable upon conversion.Rule 506(b) | Form D ↗ |
| Aug 14, 2012 | Aug 28, 2012 | $833,755fully sold | 7 | $119K | Equity, Series Seed preferred stock and the common stock issuable upon conversion.06 | Form D ↗ |
| Total, three offerings | $82,081,416 | |||||
First sale is the date the first investor in the offering committed to invest. Companies must file Form D within 15 days of that date, so filing dates run later.
Leadership Team
Executive officers and directors listed on Vumedi's Form D filed May 22, 2025.
RG
Roman Giverts
Chief Executive Officer and director
JW
Jon Warner
Director
VC
Victor Clavelli
Director
SL
Steve LaCommare
Executive officer
AA
Andrew Adams
Director
MA
Mark Anderson
Director
Earlier filings also listed Robert Winder (chief executive officer and director, last listed Aug 2012).